JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

Journal:
Science Advances
Published:
DOI:
10.1126/sciadv.abe4724
Affiliations:
31
Authors:
50
Institutions Authors Share
University of Pisa (UNIPI), Italy
9.000000
0.18
Complejo Hospitalario Universitario de Albacete, Spain
9.000000
0.18
Karolinska Institute (KI), Sweden
4.000000
0.08
University Hospital "Santa Maria della Misericordia", Italy
4.000000
0.08
Oxford NanoImaging Ltd (ONI), United Kingdom (UK)
3.000000
0.06
Imperial College London (ICL), United Kingdom (UK)
2.000000
0.04
Science for Life Laboratory (SciLifeLab), Sweden
2.000000
0.04
Institute of Health Carlos III (ISCIII), Spain
2.000000
0.04
Hospital of Prato, Italy
2.000000
0.04
Research Collaboratory for Structural Bioinformatics Protein Data Bank (RCSB PDB), United States of America (USA)
2.000000
0.04
University of Rome Tor Vergata, Italy
1.000000
0.02
The Angiogenesis Foundation, United States of America (USA)
1.000000
0.02
University of Toronto (U of T), Canada
1.000000
0.02
IRCCS National Institute for Infectious Diseases (INMI), Italy
1.000000
0.02
University of Ioannina (UOI), Greece
1.000000
0.02
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore
1.000000
0.02
National University of Singapore (NUS), Singapore
1.000000
0.02
Azienda USL Toscana Centro, Italy
1.000000
0.02
University Hospital of Pisa, UNIPI, Italy
1.000000
0.02
BenevolentAI Limited, United Kingdom (UK)
1.000000
0.02
Institute of Molecular Biotechnology (IMBA), Austria
0.500000
0.01
The University of British Columbia (UBC), Canada
0.500000
0.01